Dr. Cesar Augusto Perez Hernandez, MD Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Carretera 30 Interseccion 921, Barrio Tejas, Las Piedras, PR 00771 Phone: 787-733-2347 |
News Archive
Virginia Tech scientists have developed a new cancer drug that uses gold nanoparticles created by the biotech firm CytImmune Sciences to deliver paclitaxel — a commonly used chemotherapy drug directly to a tumor.
TearScience, a privately-held medical device company, today announced the completion of $44.5 million of Series C funding from new investors Essex Woodlands Health Ventures, Investor Growth Capital and General Catalyst. The company's existing investors, De Novo Ventures, Spray Ventures and Quaker Bio Ventures completed the round. The funding will allow TearScience to commercialize its devices designed for use by eye care professionals to diagnose and treat the most common form of chronic dry eye disease.
ACTIVATE, the innovative, enhanced vitamin beverage ideal for people with active lifestyles, today announced it will extend its sustainability efforts and partner with American Forests to celebrate Earth Month through a unique "Plant a Tree" in-store initiative.
Significant clinical variations exist among patients with the most common type of liver cancer called hepatocellular carcinoma (HCC), depending on the viral cause of the disease -hepatitis B virus (HBV) or hepatitis C virus (HCV). These differences suggest that hepatitis status should be considered when developing treatment plans for newly diagnosed patients, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 7 days ago